All In MedTech

FDA Clearance Tracker · P200025

ClearVisc Ophthalmic Viscosurgical Device (OVD)

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 19, 2026Latest source record: Mar 23, 2021 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Mar 23, 2021

Approved

Time to decision

337 days

Received Apr 20, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P200025
Device name
ClearVisc Ophthalmic Viscosurgical Device (OVD)
Applicant
Bausch Health
Applicant location
Bridgewater, NJ
Received
Apr 20, 2020
Decided
Mar 23, 2021
Decision
Approved

Device type

Device class
Class III
Regulation
21 CFR 886.4275
Specialty
Ophthalmology

Every decision under product code LZP

FDA's approval statement

As written in FDA's record.

Approval for the ClearVisc Ophthalmic Viscosurgical Device (OVD). ClearVisc is indicated for use as a surgical aid in ophthalmic anterior segment procedures including:1) Extraction of a cataract; and2) Implantation of an intraocular lens (IOL).

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code LZP. The earliest in FDA's data is P810031, decided Jan 14, 1983.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Bausch Health

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.